| Dr Shanna Melton, PSYD | |
|
501 Broad St Ste 306, Rome, GA 30161-3096 | |
| (706) 232-8330 | |
| (844) 873-4760 |
| Full Name | Dr Shanna Melton |
|---|---|
| Gender | Female |
| Speciality | Psychologist |
| Location | 501 Broad St Ste 306, Rome, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851432058 | NPI | - | NPPES |
| 434425435A | Medicaid | GA | |
| 434425435D | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | PSY002843 (Georgia) | Primary |
| Entity Name | Wellpsyche, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992939201 PECOS PAC ID: 2668833740 Enrollment ID: O20230804003704 |
News Archive
Santa Claus is coming to town - and Christmas eve is the one night that he must be healthy for his madcap, round-the-world dash. Like us, he's under quite a bit of stress this time of year. While we have crowded stores, visiting relatives, and lots of sugary treats that can strain our immune system, he has elves working feverishly round-the-clock, bickering reindeer, millions of letters to read, and frosty winter weather.
ArQule, Inc. and Daiichi Sankyo Co., Ltd. today announced that they will move forward with a Phase 3 clinical trial of ARQ 197, a small molecule inhibitor of the c-Met receptor tyrosine kinase, in patients with non-small cell lung cancer (NSCLC). In connection with this decision, the sponsor company, Daiichi Sankyo, will file a Special Protocol Assessment (SPA) with the U.S. Food and Drug Administration (FDA) for a trial comparing ARQ 197 plus erlotinib against erlotinib plus placebo.
A new method to boost the number of immune cells in umbilical cord blood prior to cord blood transplants for cancer patients appears to lead to a quicker rebuilding of a new immune system in the patient's body than with a conventional cord blood transplant procedure, according to new research from the Perelman School of Medicine at the University of Pennsylvania that will be presented today at the 53rd American Society of Hematology Annual Meeting.
A new study looking at the long term effects of losing substantial amounts of weight has found that it could reverse type 2 diabetes in more than a third of the patients. With the rising epidemic of obesity and type 2 diabetes around the world, this could be an important finding.
Abbott today announced results from the Phase 3 ABILITY-1 study of HUMIRA (adalimumab) in patients with active non-radiographic axial spondyloarthritis.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Shanna Melton, PSYD 58 Wellington Way Se, Rome, GA 30161-9417 Ph: () - | Dr Shanna Melton, PSYD 501 Broad St Ste 306, Rome, GA 30161-3096 Ph: (706) 232-8330 |
News Archive
Santa Claus is coming to town - and Christmas eve is the one night that he must be healthy for his madcap, round-the-world dash. Like us, he's under quite a bit of stress this time of year. While we have crowded stores, visiting relatives, and lots of sugary treats that can strain our immune system, he has elves working feverishly round-the-clock, bickering reindeer, millions of letters to read, and frosty winter weather.
ArQule, Inc. and Daiichi Sankyo Co., Ltd. today announced that they will move forward with a Phase 3 clinical trial of ARQ 197, a small molecule inhibitor of the c-Met receptor tyrosine kinase, in patients with non-small cell lung cancer (NSCLC). In connection with this decision, the sponsor company, Daiichi Sankyo, will file a Special Protocol Assessment (SPA) with the U.S. Food and Drug Administration (FDA) for a trial comparing ARQ 197 plus erlotinib against erlotinib plus placebo.
A new method to boost the number of immune cells in umbilical cord blood prior to cord blood transplants for cancer patients appears to lead to a quicker rebuilding of a new immune system in the patient's body than with a conventional cord blood transplant procedure, according to new research from the Perelman School of Medicine at the University of Pennsylvania that will be presented today at the 53rd American Society of Hematology Annual Meeting.
A new study looking at the long term effects of losing substantial amounts of weight has found that it could reverse type 2 diabetes in more than a third of the patients. With the rising epidemic of obesity and type 2 diabetes around the world, this could be an important finding.
Abbott today announced results from the Phase 3 ABILITY-1 study of HUMIRA (adalimumab) in patients with active non-radiographic axial spondyloarthritis.
› Verified 1 days ago
Dr. John Azar-dickens, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 106 E 5th Ave, Rome, GA 30161 Phone: 706-232-6743 Fax: 706-232-8050 | |
Dr. Paul Schlachter, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1345 Redmond Road, Rome, GA 30165 Phone: 910-742-9243 Fax: 888-746-1787 | |
Randell Leon Elkins Jr., PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 701 Broad St Ste 350, Rome, GA 30161 Phone: 706-295-2028 Fax: 706-295-2062 | |
Dr. Elizabeth Austin, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 106 E 5th Ave, Rome, GA 30161 Phone: 706-232-8330 Fax: 706-232-8331 | |
Dr. Judith Tutin, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 519 Broad St, Suite 202, Rome, GA 30161 Phone: 706-232-5544 Fax: 888-543-1173 | |
Dr. Alice Eleanor Wiener, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 412 E 1st St, Rome, GA 30161 Phone: 706-235-6990 Fax: 706-235-4985 | |
Jason Randolph Dunn, PSYD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 701 Broad St, Ste 350, Rome, GA 30161 Phone: 762-235-3640 Fax: 706-295-2062 |